Graf Akcie AFMD (Affimed N.V.). Diskuze k akciím AFMD. Aktuální informace AFMD.

Základní informace o společnosti Affimed N.V. (Akcie AFMD)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 694.09M
Hodnota podniku (EV) N/A
Tržby N/A
EBITDA N/A
Zisk -€31.67
Růst v tržbách Q/Q 129.91 %
Růst v tržbách Y/Y 134.24 %
P/E (Cena vůči ziskům) 0.00
Forward P/E -26.91
EV/Sales 10.66
EV/EBITDA N/A
EV/EBIT N/A
PEG N/A
Price/Sales 12.34
P/FCF N/A
Price/Book 8.34
Účetní hodnota na akcii 0.71
Hotovost na akcii N/A
FCF vůči ceně -2.88 %
Počet zaměstnanců 158
Tržba na zaměstnance €225.222k
Profit margin -143.35 %
Operating margin -81.60 %
Gross margin 100.00 %
EBIT margin -81.60 %
EBITDA margin -157.57 %
EPS - Zisk na akcii N/A
EPS - Kvartální růst 0.00 %
EPS - Očekávaný růst příští rok 77.78 %
Return on assets -9.87 %
Return on equity -31.66 %
ROIC -24.19 %
ROCE -13.96 %
Dluhy/Equity 1.44
Čistý dluh/EBITDA 10.32
Current ratio 3.93
Quick Ratio 3.89
Volatilita 4.87
Beta 1.38
RSI 45.20
Cílová cena analytiků 8
Známka akcie (dle analytiků) N/A
Insider ownership 2.79 %
Institutional ownership 67.62 %
Počet akcií 98.287M
Procento shortovaných akcií 3.39 %
Short ratio 2.96 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2014
Země Germany

Finanční výsledky akcie AFMD

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$23.958$28.031$2.272$6.987$8.397$4.49$6.755$1.508
Cost Of Goods Sold--------
Gross Profit$23.958$28.031$2.272$6.987$8.397$4.49$6.755$1.508
Research And Development Expenses$49.046$41.51$24.289$33.397$24.438$12.75--
SG&A Expenses$11.498$11.383$9.027$9.21$8.381$2.61--
Other Operating Income Or Expenses$0.325$1.789$0.232$0.161$0.723---
Operating Expenses$60.219$51.103$33.084$42.447$32.096$15.36--
Operating Income$-36.261$-23.072$-30.812$-35.46$-23.699$-10.87$6.755$1.508
Total Non-Operating Income/Expense$0.017$0.071$-3.372$-0.255$1.226$10.52--
Pre-Tax Income$-36.244$-23.001$-34.184$-35.714$-22.473$-0.34$6.755$1.508
Income Taxes$0.005$0.001$-0.023$-0.064----
Income After Taxes$-36.249$-23.002$-34.161$-35.65$-22.473$-0.34$6.755$1.508
Other Income--------
Income From Continuous Operations$-36.249$-23.002$-34.161$-35.65$-22.473$-0.283$-34.657$-18.402
Income From Discontinued Operations--------
Net Income$-36.249$-23.002$-34.161$-35.65$-22.473$-0.34$-34.657$-18.402
EBITDA$-35.246$-22.596$-30.415$-35.052$-23.326$-10.29$6.755$1.508
EBIT$-36.261$-23.072$-30.812$-35.46$-23.699$-10.87$6.755$1.508
Basic Shares Outstanding6461443328261616
Shares Outstanding6461443328261616
Basic EPS$-0.56$-0.38$-0.78$-1.07$-0.79$-0.01$-2.16$-1.16
EPS - Earnings Per Share$-0.56$-0.38$-0.78$-1.07$-0.79$-0.01$-2.16$-1.16
# 2020 2019 2018 2017 2016 2015
Current Ratio3.01053.00955.60267.51258.75846.5751
Long-term Debt / Capital0.00710.04040.11460.08540.04410.109
Debt/Equity Ratio0.06160.11890.2270.11840.0680.1223
Gross Margin100100100100100100
Operating Margin-151.3534-82.3088-1356.219-507.5071-282.2401-242.0935
EBIT Margin-151.3534-82.3088-1356.219-507.5071-282.2401-242.0935
EBITDA Margin-147.118-80.6109-1338.756-501.6629-277.7969-229.1759
Pre-Tax Profit Margin-151.2832-82.056-1504.627-511.1498-267.6408-7.5724
Net Profit Margin-151.3019-82.0603-1503.632-510.2313-267.6408-7.5724
Asset Turnover0.19040.20430.04660.12950.09530.0806
Inventory Turnover Ratio------
Receiveable Turnover14.433916.60951.8242.88.26453.621
Days Sales In Receivables25.287721.9754200.1144130.357144.1649100.8018
ROE - Return On Equity-83.7018-48.536-95.706-83.1359-30.0844-0.6697
Return On Tangible Equity-83.9995-48.6038-95.9034-83.2541-30.1167-0.6709
ROA - Return On Assets-28.805-16.7654-70.0287-66.099-25.515-0.508
ROI - Return On Investment-83.1044-46.5745-84.7413-76.0385-28.7576-0.5967
Book Value Per Share0.5680.75910.76281.28922.246-
Operating Cash Flow Per Share-1.47141.62490.4088-0.3462-0.1814-0.5413
Free Cash Flow Per Share-1.4811.62680.4014-0.3444-0.178-0.5544